Contineum Therapeutics (CTNM) Institutional Ownership $10.58 -0.59 (-5.28%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$10.96 +0.38 (+3.59%) As of 09/3/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)Number ofInstitutional Buyers(last 12 months)38TotalInstitutional Inflows(last 12 months)$49.90MNumber ofInstitutional Sellers(last 12 months)12TotalInstitutional Outflows(last 12 months)$18.39M Get CTNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CTNM Institutional Buying and Selling by Quarter Contineum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc11,400$45K0.0%N/A0.041% 8/15/2025 Perceptive Advisors LLC699,486$2.78M0.2%-51.5%2.704% 8/15/2025 Bridgeway Capital Management LLC19,200$76K0.0%N/A0.074% 8/14/2025 Jane Street Group LLC20,321$81K0.0%N/A0.079% 8/14/2025 RBF Capital LLC40,000$159K0.0%N/A0.155% 8/14/2025 Qube Research & Technologies Ltd10,924$43K0.0%N/A0.042% 8/13/2025 Marshall Wace LLP28,685$114K0.0%-7.7%0.111% 8/13/2025 Saturn V Capital Management LP319,348$1.27M0.5%-43.1%1.234% 8/13/2025 Norges Bank169,729$674K0.0%N/A0.656% 8/12/2025 Franklin Resources Inc.1,698,825$6.74M0.0%+7.8%6.567% Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2025 Versant Venture Management LLC542,628$2.15M2.6%-40.9%2.098% 8/8/2025 Geode Capital Management LLC71,303$283K0.0%-63.1%0.276% 8/7/2025 Monaco Asset Management SAM75,000$298K0.1%N/A0.290% 8/1/2025 Y Intercept Hong Kong Ltd35,156$140K0.0%N/A0.136% 6/27/2025 Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055% 5/28/2025 Strs Ohio3,900$27K0.0%N/A0.015% 5/16/2025 Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055% 5/16/2025 Dynamic Technology Lab Private Ltd16,838$118K0.0%N/A0.065% 5/16/2025 ADAR1 Capital Management LLC168,765$1.18M0.2%+105.2%0.652% 5/13/2025 Altium Capital Management LLC303,857$2.12M5.1%-9.0%1.174% 5/12/2025 Nuveen LLC13,307$93K0.0%N/A0.051% 5/9/2025 Charles Schwab Investment Management Inc.51,202$357K0.0%-7.5%0.198% 2/17/2025 Squarepoint Ops LLC217,239$3.18M0.0%-37.9%0.843% 2/17/2025 Stempoint Capital LP265,833$3.89M1.0%N/A1.031% 2/17/2025 Red Tree Management LLC638,158$9.35M6.2%N/A2.475% 2/17/2025 Polar Capital Holdings Plc43,604$639K0.0%-79.9%0.169% 2/17/2025Nuveen Asset Management LLC13,307$195K0.0%N/A0.052% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,860$86K0.0%+90.4%0.023% 2/17/2025 Janus Henderson Group PLC68,320$1.00M0.0%N/A0.265% 2/17/2025 Deutsche Bank AG16,079$236K0.0%N/A0.062% 2/17/2025 Bank of America Corp DE9,132$134K0.0%+63.4%0.035% 2/14/2025 Schonfeld Strategic Advisors LLC125,995$1.85M0.0%N/A0.489% 2/14/2025 Northern Trust Corp89,262$1.31M0.0%+42.3%0.346% 2/14/2025 MetLife Investment Management LLC7,029$103K0.0%N/A0.027% 2/14/2025 Altium Capital Management LLC334,000$4.89M1.4%-9.5%1.296% 2/13/2025 Marshall Wace LLP10,836$159K0.0%N/A0.042% 2/13/2025 Strategies Wealth Advisors LLC25,000$366K0.0%N/A0.097% 2/13/2025 Barclays PLC16,286$239K0.0%+96.0%0.063% 2/13/2025 Legal & General Group Plc3,631$53K0.0%+74.0%0.014% 2/13/2025 ADAR1 Capital Management LLC82,234$1.21M0.2%+817.1%0.319% 50-yr Wall Street Legend Issues Mag 7 Warning (Ad)A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW kind of AI stock.Details here...2/13/2025 Wells Fargo & Company MN10,755$158K0.0%+419.3%0.042% 2/12/2025 Geode Capital Management LLC188,408$2.76M0.0%+46.4%0.731% 2/12/2025 Franklin Resources Inc.1,445,565$21.18M0.0%-0.1%5.607% 2/12/2025 Norges Bank169,729$2.49M0.0%N/A0.658% 2/12/2025 JPMorgan Chase & Co.28,426$416K0.0%+1,040.7%0.110% 2/12/2025 WINTON GROUP Ltd39,738$582K0.0%+256.8%0.154% 2/11/2025 Corebridge Financial Inc.5,215$76K0.0%+73.1%0.020% 2/6/2025 Charles Schwab Investment Management Inc.55,330$811K0.0%+27.8%0.215% 2/4/2025 Bank of New York Mellon Corp18,738$275K0.0%+32.3%0.073% 1/30/2025 Rhumbline Advisers8,233$121K0.0%+36.3%0.032% 11/27/2024 Franklin Resources Inc.1,447,550$27.71M0.0%+130.9%5.615% 11/19/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/16/2024 Geode Capital Management LLC128,676$2.46M0.0%-17.7%0.500% 11/15/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/15/2024 State Street Corp113,566$2.17M0.0%+23.7%0.442% 11/14/2024 Suvretta Capital Management LLC1,720,000$32.92M1.1%-16.2%6.687% 11/13/2024 BNP Paribas Financial Markets6,743$129K0.0%+1,248.6%0.026% 11/13/2024 FMR LLC696,927$13.34M0.0%+115.4%2.710% 11/12/2024 Charles Schwab Investment Management Inc.43,295$829K0.0%-16.4%0.168% 8/16/2024 Perceptive Advisors LLC1,566,668$27.59M0.7%N/A6.091% 8/16/2024 Driehaus Capital Management LLC66,667$1.17M0.0%N/A0.259% 8/14/2024 Squarepoint Ops LLC150,000$2.64M0.0%N/A0.583% 8/14/2024 Sandia Investment Management LP5,000$88K0.1%N/A0.019% 8/9/2024 Johnson & Johnson1,979,173$34.85M8.7%N/A7.694% 8/8/2024 Versant Venture Management LLC918,163$16.17M20.9%N/A3.569% 8/1/2024 Rhumbline Advisers6,722$118K0.0%N/A0.026% 7/26/2024 Bank of New York Mellon Corp20,232$356K0.0%N/A0.079% (Data available from 1/1/2016 forward) CTNM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTNM shares? During the previous two years, 49 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.92M), FMR LLC ($13.34M), Red Tree Management LLC ($9.35M), Franklin Resources Inc. ($6.74M), Stempoint Capital LP ($3.89M), and Squarepoint Ops LLC ($3.18M).Learn more on Contineum Therapeutics' institutional investors. Which institutional investors have been buying Contineum Therapeutics' stock? Of the 44 institutional investors that purchased Contineum Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Johnson & Johnson ($1.98M), Perceptive Advisors LLC ($1.57M), Franklin Resources Inc. ($943.19K), Versant Venture Management LLC ($918.16K), Red Tree Management LLC ($638.16K), FMR LLC ($373.33K), and Norges Bank ($339.46K). How much institutional buying is happening at Contineum Therapeutics? Institutional investors have bought a total of 3,458,570 shares in the last 24 months. This purchase volume represents approximately $49.90M in transactions. Which of Contineum Therapeutics' major shareholders have been selling company stock? Of the 12 institutional investors that sold Contineum Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($741.76K), Versant Venture Management LLC ($375.54K), Suvretta Capital Management LLC ($333.33K), Saturn V Capital Management LP ($241.63K), Polar Capital Holdings Plc ($173.00K), Geode Capital Management LLC ($149.49K), and Squarepoint Ops LLC ($132.76K). How much institutional selling is happening at Contineum Therapeutics? Institutional investors have sold a total of 2,254,060 shares in the last 24 months. This volume of shares sold represents approximately $18.39M in transactions. Related Companies GPCR Institutional Ownership STOK Institutional Ownership CRMD Institutional Ownership NUVB Institutional Ownership SYRE Institutional Ownership ATAI Institutional Ownership MLYS Institutional Ownership PRAX Institutional Ownership CRON Institutional Ownership ORIC Institutional Ownership This page (NASDAQ:CTNM) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
